AUROPHARMA

Aurobindo Pharma Limited Gets USFDA VAI Status for Unit-V • 🏭 USFDA Update: API facility (Unit-V) classified as VAI (Voluntary Action Indicated) • 📋 Inspection Outcome: Earlier Form 483 with 3 observations • ✅ Closure Status: USFDA issues EIR; inspection now closed • 🌍 Regulatory Comfort: No critical observations impacting operations • 📈 Supply Continuity: Supports stable US market supplies 🟢 Impact: Positive Regulatory closure without major issues boosts compliance confidence and reduces USFDA overhang.